BioCentury | Jan 31, 2005
Finance

Ebb & Flow

...ion channels. Investors in the C round were Forward Ventures; Boston Millennia; CMEA; Novel Bioventures; Yamanouchi Venture Capital...
BioCentury | Jan 25, 2005
Financial News

Predix raises $43M

...C round led by Forward Ventures; Boston Millennia; and CMEA. Other investors included Novel Bioventures; Yamanouchi Venture Capital...
BioCentury | Sep 20, 2004
Emerging Company Profile

Corporate Profile

...Number of employees: 6 Funds raised: E14 million ($16.5 million) Investors: Aravis; Novartis Venture Fund; Yamanouchi Venture Capital...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...MVM Ltd.; ABN AMRO; 3i; Green Highlander Cellzome Germany $32.1 Invesco; BioFrontier; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 24, 2003
Finance

Ebb & Flow

...targets and lead pairs. Other investors in the round included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 18, 2003
Financial News

Cellzome raises EUR 30 million

...C round led by Invesco Private Capital. Other investors included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Finance

Ebb & Flow

...D financing was led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Finance

Neuro money

...Neuro money Company Businesses Raised (M) Deal date Investors Memory Pharma Neurological $40.0 25-Mar-02 Biomedicine; Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Financial News

Memory raises $40 million

...series D financing led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...
BioCentury | Dec 4, 2000
Finance

Trailing indicator

...Meanwhile, Japanese pharma company Yamanouchi has set up a U.S. VC unit in Palo Alto. Yamanouchi Venture Capital...
Items per page:
1 - 10 of 11
BioCentury | Jan 31, 2005
Finance

Ebb & Flow

...ion channels. Investors in the C round were Forward Ventures; Boston Millennia; CMEA; Novel Bioventures; Yamanouchi Venture Capital...
BioCentury | Jan 25, 2005
Financial News

Predix raises $43M

...C round led by Forward Ventures; Boston Millennia; and CMEA. Other investors included Novel Bioventures; Yamanouchi Venture Capital...
BioCentury | Sep 20, 2004
Emerging Company Profile

Corporate Profile

...Number of employees: 6 Funds raised: E14 million ($16.5 million) Investors: Aravis; Novartis Venture Fund; Yamanouchi Venture Capital...
BioCentury | May 17, 2004
Finance

U.S. investment in Europe

...MVM Ltd.; ABN AMRO; 3i; Green Highlander Cellzome Germany $32.1 Invesco; BioFrontier; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 24, 2003
Finance

Ebb & Flow

...targets and lead pairs. Other investors in the round included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 18, 2003
Financial News

Cellzome raises EUR 30 million

...C round led by Invesco Private Capital. Other investors included Biofrontier Partners; SG Asset Management; Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Finance

Ebb & Flow

...D financing was led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Finance

Neuro money

...Neuro money Company Businesses Raised (M) Deal date Investors Memory Pharma Neurological $40.0 25-Mar-02 Biomedicine; Yamanouchi Venture Capital...
BioCentury | Mar 25, 2002
Financial News

Memory raises $40 million

...series D financing led by International BM Biomedicine Holdings' Biomedicine L.P. affiliate. Other investors included Yamanouchi Venture Capital...
BioCentury | Dec 4, 2000
Finance

Trailing indicator

...Meanwhile, Japanese pharma company Yamanouchi has set up a U.S. VC unit in Palo Alto. Yamanouchi Venture Capital...
Items per page:
1 - 10 of 11